|Addressing clinical & translational research needs associated with child health.||Child Health|
October 7, 2015
Joseph B. Martin Conference Center - Rotunda
Harvard Medical School
Registration is required by October 2.
Through research, we now recognize that many exposures in infancy and early childhood exert profound effects on childhood, later in life, and even intergenerational health. Long-term health consequences of adverse early-life exposures include not only cardiovascular, renal, and neurological conditions, but also psychological and metabolic processes.
The purpose of this year's day-long symposium is to bring together leading national and international laboratory, clinical, and population scientists with Harvard's child health research community to inspire novel, cutting-edge research in this critically important area. The symposium will incorporate T1-T4 translational research into each session and will highlight emerging concepts, tools, and technologies.
Welcome and Opening Remarks
Linda J. Van Marter, MD, MPH
Vice Chair, Department of Pediatric Newborn Medicine, Brigham and Women's Hospital
Developmental Origins: From Evidence to Policy
Matthew Gillman, MD, SM
Director of the Obesity Prevention Program in the Department of Population Medicine, Harvard Pilgrim Healthcare
Topic 1: Fetal-Maternal Contributions
David Haig, PhD
George Putnam Professor of Biology, Department of Organismic and Evolutionary Biology, Harvard University
Leslie Myatt, PhD
Professor of Obstetrics and Gynecology and Director, Center for Pregnancy and Newborn Research, University of Texas Health Science Center San Antonio
Andrea Baccarelli, MD, PhD, MPH
Mark and Catherine Winkler Associate Professor of Environmental Epigenetics, Harvard T.H. Chan School of Public Health
Topic 2: Origins in the First 1000 Days
Mary-Elizabeth Patti, MD, FACP
Investigator and Adult Endocrinologist, Joslin Diabetes Center; Assistant Professor of Medicine, Harvard Medical School
C. Ronald Kahn, MD
Chief Academic Officer, Joslin Diabetes Center, Mary K. Iacocca Professor of Medicine, Harvard Medical School
Alessio Fasano, MD
Chief, Division of Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children
Terrie Inder, MD, MB, ChB
Chair, Department of Pediatric Newborn Medicine, Brigham and Women's Hospital
Charles A. Nelson III, PhD
Professor of Pediatrics and Neuroscience, Harvard Medical School
Topic 3: Translating Knowledge of Developmental Origins to Health Care Interventions and Policy
Ross Hammond, PhD
Senior Fellow, Economic Studies Program, Director, Center on Social Dynamics & Policy, The Brookings Institution
Caroline Fall, MBChB, DM, FRCP, FRCPCH
Professor of International Paediatric Epidemiology, University of Southampton
Michael C. Lu, MD, MS, MPH
Associate Professor of Obstetrics & Gynecology and Public Health, UCLA
Jack P. Shonkoff, MD
Julius B. Richmond FAMRI Professor of Child Health and Development, Harvard T.H. Chan School of Public Health and Harvard Graduate School of Education
If you are interested in presenting a poster at the symposium, please check back in a few weeks for more information. Details about the poster session and application information will be made available on this page.
The Child Health Program works to foster the development of programs, resources, and strategies that support innovative and collaborative research to improve the health and well-being of children. The program works across Harvard University, its affiliated institutions, and the national CTSA Consortium.
Paramount to the initiative's mission is to build capacity among Harvard University's child health community to conduct innovative clinical and translational research across the lifecourse.
To achieve our mission, the Child Health Program works in partnership with Harvard Catalyst programs and resources and Harvard-affiliated institutions to identify and promote strategies that effectively address the unique needs of child health researchers. Efforts include convening the child health research community across affiliate institutions to encourage and support development of the best possible team science and awarding pilot funding to child health researchers for innovative clinical and translation research projects. A further programmatic goal is to encourage the inclusion of children as a key population to consider across Harvard Catalyst programs and resources, particularly those that optimize transfer of knowledge from clinical and translational science laboratories into the development, testing, and adoption of innovative screening tools, diagnostics, and therapeutics.